AG
ALNA

Algert Global’s Allena Pharmaceuticals ALNA Stock Holding History

Algert Global’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-17,340
Closed -$27K – 513
2020
Q2 		$27K Sell
17,340
-18,300
-51% -$30.7K 0.01% 407
2020
Q1 		$34K Sell
35,640
-1,200
-3% -$2.4K 0.01% 390
2019
Q4 		$101K Buy
+36,840
New +$121K 0.03% 350

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Algert Global's ALNA Position: Q3 2020 in Review

Algert Global sold out of Allena Pharmaceuticals (ALNA) in Q3 2020, closing a stake of 17,340 shares — an estimated $27K sold.

Algert Global first reported a position in ALNA in Q4 2019 and held it in 3 quarters. The position peaked at $101K in Q4 2019. 24 funds tracked by Wall St. Rank hold ALNA as of Q3 2020.

  • Algert Global reported no remaining Allena Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Algert Global sold 17,340 Allena Pharmaceuticals shares in Q3 2020, an estimated $27K.
  • Algert Global first reported a position in Allena Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • Algert Global's Allena Pharmaceuticals position peaked at $101K in Q4 2019.
  • 24 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2020.

Based on Algert Global's 13F filing for Q3 2020, filed 16 Nov 2020.